Testing & tracking
Compare the routes.
Four testing pathways and three genetic tracking tests — side by side, so the right route is a quick decision.
Testing pathways
Side by side
| Twin Blood 600 | Twin Exome | Twin Liquid | Twin Tissue | |
|---|---|---|---|---|
| Cancer context | Blood cancers | Solid tumours | Solid tumours | Solid tumours |
| Description | DNA and RNA together, from blood or bone marrow. | Whole-exome sequencing (WES) across every protein-coding gene. | 523-gene ctDNA panel from plasma. Hereditary testing included for germline filtering. | 335-gene panel. FFPE or fresh tumour tissue. |
| Sample | Blood or bone marrow. | Tumour tissue — FFPE or fresh. | Plasma. | FFPE or fresh tumour tissue. |
| Strengths | DNA and RNA in one route — mutations and fusions read together. | The broadest view: every protein-coding gene, not a preselected list. | A blood draw instead of a biopsy. | Reads the tumour directly, from the sample most patients already have. |
Integrated analytical features
SNVs and indels · Copy-number variations (CNVs) · Gene fusions · Tumour mutational burden (TMB) · Microsatellite instability (MSI) · Homologous recombination deficiency (HRD) · HLA typing · Pharmacogenomics (PGx)
Twin tracks